Primary Record
mestanolone
- In stock
- 6,849 g
- Purity
- 98.9 %
- CAS
- 521-11-9
Compound Identifiers & Properties
- CAS
- 521-11-9
- PubChem CID
- 10633
- SMILES
- C[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C
- Canonical SMILES
- C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O
Names & Synonyms
- mestanolone
- Assimil
- Tantarone
- Methybol
- Methylantalon
- Mesanolon
- Androstalone
- Ermalone
- Preroide
- Andoron
- Mestanolona
- Mestalone
- Mestanolonum
- Mestanolon
- Mestaline
- Methylantalone
- Mesanolone
- Preroid
- Ermalone (VAN)
- Methyldihydrotestosterone
- Methylandrostanolone
- AAEthUAmicroAu
- mestanolone(jan)
- 521-11-9
- Mesanolon (TN)
- 17alpha-methyl-DHT
- Mestanolonum [INN-Latin]
- Mestanolona [INN-Spanish]
- 17alpha-Methylandrostanolone
- Stanozolol EP Impurity A
- AAO masculineI feminine
- DTXSID0048973
- Mestanolone [INN:BAN:JAN]
- 17alpha-Methyldihydrotestosterone
- 17-Methyldihydrotestosterone
- AC1L1VMD
- Mestanolone (JAN/INN)
- MESTANOLONE [MI]
- RefChem:811179
- MESTANOLONE [INN]
- MESTANOLONE [JAN]
- WYZDXEKUWRCKOB-YDSAWKJFSA-N
- Stanozolol impurity A CRS
- UNII-S712YZ168E
- AC1Q6J2V
- 17-alpha-Methyldihydrotestosterone
- MESTANOLONE [MART.]
- S712YZ168E
- NSC 18219
- NSC-18219
- RU 143
- DTXCID3028899
- MESTANOLONE [WHO-DD]
- MLS000759515
- MLS001424090
- Mestanolone [BAN:INN:JAN]
- SCHEMBL146678
- EINECS 208-302-6
- 17alpha-methylandrostan-3-on-17beta-ol
- CHEMBL261514
- DEA No. 4000
- (17beta)-isomer of mestanolone
- 17.alpha.-Methyldihydrotestosterone
- 17alpha-Methylandrostan-17beta-ol-3-one
- C20H32O2
- CHEBI:31825
- BRN 3207223
- MFCD00021158
- 17beta-Hydroxy-17alpha-methyl-5alpha-androstan-3-one
- HMS2051M18
- 17alpha-Methyl-5alpha-dihydrotestosterone
- 17beta-Hydroxy-17alpha-methyl-3-androstanone
- BCP10775
- CID10633
- HY-B1903
- NSC18219
- ZINC4216870
- 17beta-Hydroxy-17-methyl-androstan-3-one
- Tox21_113424
- BDBM50423547
- CID:10633
- LMST02020027
- MSK8504-100A
- RU-143
- (5beta,17beta)-isomer of mestanolone
- 17-Hydroxy-17-methylandrostan-3-one
- AKOS015895448
- MSK8504-1000A
- (5beta,17alpha)-isomer of mestanolone
- ACN-032022
- C20-H32-O2
- CCG-100893
- CS-5233
- J5.180B
- Mestanolone (1 mg/ml in Acetonitrile)
- Mestanolone 100 microg/mL in Methanol
- NC00143
- Mestanolone (1.0mg/ml in Acetonitrile)
- NCGC00183127-01
- 17alpha-methyl-5alpha-androstan-17beta-ol-3-one
- 17Alpha-methyl-delta1-dihydrotestosterone
- 17beta-Hydroxy-17-methyl-5alpha-androstan-3-one
- 5alpha-Androstane-17alpha-methyl-17beta-ol-3-one
- AC-16142
- AN-45526
- CAS-521-11-9
- CPD000238198
- FM156785
- LS-19398
- SID:53789791
- SMR000238198
- 17.alpha.-Methyl-5.alpha.-dihydrotestosterone
- 17 alpha-methyl-5 alpha-dihydrotestosterone
- 17-beta-Hydroxy-17-methyl-5-alpha-androstan-3-one
- Androstan-3-one, (5.alpha.,17.beta.)-
- STANOZOLOL IMPURITY A [EP IMPURITY]
- TL8003443
- 17 alpha-methylandrostan-17 beta-ol-3-one
- 17alpha-Methyl-17beta-hydroxy-5alpha-androstan-3-one
- 5-alpha-Androstane-17-alpha-methyl-17-beta-ol-3-one
- NS00032423
- 17B-hydroxy-17A-methyl-5A-androstan-3-one
- 4-08-00-00656 (Beilstein Handbook Reference)
- Androstan-3-one, 17-hydroxy-17-methyl-, (5a,17b)-
- 5alpha-Androstan-3-one, 17beta-hydroxy-17-methyl-
- D01533
- Mestanolone Solution in Acetonitrile, 100ug/mL
- 17.beta.-Hydroxy-17-methyl-5.alpha.-androstan-3-one
- Mestanolone Solution in Acetonitrile, 1000ug/mL
- (1/4)x paragraph signthornCaO masculineI feminine
- 17-.alpha.-Methylandrostan-17-.beta.-ol-3-one
- 521M119
- A828928
- C008376
- (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-one
- 17 beta-hydroxy-17-methyl-5 alpha-androstan-3-one
- 5.alpha.-Androstan-3-one, 17.beta.-hydroxy-17-methyl-
- 5.alpha.-Androstane-17.alpha.-methyl-17.beta.-ol-3-one
- Q1924446
- (5alpha,17beta)-17-hydroxy-17-methylandrostan-3-one
- 17.alpha.-Methyl-17.beta.-hydroxy-5.alpha.-androstan-3-one
- 17.ALPHA.-METHYLANDROSTAN-17.BETA.-OL-3-ONE
- 17.ALPHA.-METHYLANDROSTAN-3-ON-17.BETA.-OL
- 17.beta.-Hydroxy-17.alpha.-methyl-5.alpha.-androstan-3-one
- 5-alpha-ANDROSTAN-3-ONE, 17-beta-HYDROXY-17-METHYL-
- Androstan-3-one, 17-hydroxy-17-methyl-, (5alpha,17beta)-
- Androstan-3-one, 17-hydroxy-17-methyl-, (5-alpha,17-beta)-
- (5-alpha,17-beta)-17-Hydroxy-17-methylandrostan-3-one
- 17 alpha-methyl-17 beta-hydroxy-5 alpha-androstan-3-one
- 17.beta.-Hydroxy-17-methyl-5.alpha.-androstan-3-one #
- 17.BETA.-HYDROXY-17.ALPHA.-METHYL-3-ANDROSTANONE
- 17|A-(1/4)x>>u paragraph signthornCaO masculineI feminine
- 5.alpha.-Androstan-3-on-17.beta.-ol, 17.alpha.-methyl
- 17alpha-Methylandrostan-17beta-ol-3-one, analytical standard
- (5.ALPHA.,17.BETA.)-17-HYDROXY-17-METHYLANDROSTAN-3-ONE
- 17|A-oC>>u-17|A-(1/4)x>>u-5|A-EthUcThornIe-3-I feminine
- 5|A-EthUcThornIe-17|A-(1/4)x>>u-17|A- (1/4)-3-I feminine
- Androstan-3-one, 17-hydroxy-17-methyl-, (5.alpha.,17.beta.)-
- (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13,17-trimethylhexadecahydro-3H-cyclopenta[a]phenanthren-3-one
- Stanozolol impurity A, European Pharmacopoeia (EP) Reference Standard
- (1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-7-one
- (5S,8R,10S,13S,17S)-17-Hydroxy-10,13,17-trimethyl-hexadecahydro-cyclopenta[a]phenanthren-3-one
- (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13,17-trimethyltetradecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one
- 208-302-6
- Androstan-3-one, 17-hydroxy-17-methyl-, (5a,17ss)-; 5a-Androstan-3-one, 17ss-hydroxy-17-methyl- (6CI,7CI,8CI); 17a-Methyl-17ss-hydroxy-5a-androstan-3-one; 17a-Methyl-5a-androstan-17ss-ol-3-one; 17a-Methyl-5a-dihydrotestosterone; 17a-Methylandrostan-17ss-ol-3-one; 17a-Methylandrostan-3-on-17ss-ol; 17a-Methylandrostanolone; 17a-Methyldihydrotestosterone; 17ss-Hydroxy-17-methyl-5a-androstan-3-one; 17ss-Hydroxy-17a-methyl-3-androstanone; 17ss-Hydroxy-17a-methyl-5a-androstan-3-one; 5a-Androstan-17a-methyl-17ss-ol-3-one; Androstalone; Assimil; Ermalone; Mestalone; Mestanolon; Mestanolone; Methybol; Methylandrostanolone; Methylantalon; NSC 18219; Preroide; RU 143; Tantarone; Stanozolol EP impurity A